{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:13:07Z","timestamp":1792181587502,"version":"4.4.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA103314"],"award-info":[{"award-number":["CA103314"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001824","name":"Czech Science Foundation","doi-asserted-by":"publisher","award":["21\\u201314082S"],"award-info":[{"award-number":["21\\u201314082S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"Univerzita Karlova v Praze","doi-asserted-by":"publisher","award":["207043"],"award-info":[{"award-number":["207043"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.biopha.2025.118532","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T20:25:50Z","timestamp":1757363150000},"page":"118532","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Molecular impact of NOTCH signaling dysregulation on ovarian cancer progression, chemoresistance, and taxane response"],"prefix":"10.1016","volume":"191","author":[{"given":"Kamila","family":"Koucka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alzbeta","family":"Spalenkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Seborova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tereza","family":"Tesarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Ehrlichova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivona","family":"Krus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Holy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Rob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hruda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Bouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alena","family":"Bartakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vendula","family":"Smoligova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3628-1161","authenticated-orcid":false,"given":"Iwao","family":"Ojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hersch","family":"Bendale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Mrhalova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Kopeckova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Soucek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radka","family":"Vaclavikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118532_bib1","unstructured":"Cancer of the Ovary - Cancer Stat Facts Available online: \u3008https:\/\/seer.cancer.gov\/statfacts\/html\/ovary.html\u3009 (accessed on 26 February 2022)."},{"key":"10.1016\/j.biopha.2025.118532_bib2","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.biopha.2025.118532_bib3","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nrc4019","article-title":"Rethinking ovarian cancer II: reducing mortality from High-Grade serous ovarian cancer","volume":"15","author":"Bowtell","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2025.118532_bib4","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.3390\/ijms17122113","article-title":"Molecular characterization of epithelial ovarian cancer: implications for diagnosis and treatment","volume":"17","author":"Rojas","year":"2016","journal-title":"IJMS"},{"key":"10.1016\/j.biopha.2025.118532_bib5","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ygyno.2016.11.019","article-title":"Worldwide comparison of ovarian cancer survival: histological group and stage at diagnosis (Concord-2)","volume":"144","author":"Matz","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.biopha.2025.118532_bib6","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jamaoncol.2023.0197","article-title":"Advances in ovarian cancer care and unmet treatment needs for patients with platinum resistance: a narrative review","volume":"9","author":"Richardson","year":"2023","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.biopha.2025.118532_bib7","unstructured":"Ovarian Cancer Survival | Cancer Research UK Available online: \u3008https:\/\/www.cancerresearchuk.org\/about-cancer\/ovarian-cancer\/survival\/\u3009 (accessed on 17 October 2024)."},{"key":"10.1016\/j.biopha.2025.118532_bib8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1756-9966-31-14","article-title":"Therapeutic strategies in epithelial ovarian cancer","volume":"31","author":"Kim","year":"2012","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2025.118532_bib9","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/AOG.0000000000004173","article-title":"Updates and new options in advanced epithelial ovarian cancer treatment","volume":"137","author":"Kurnit","year":"2021","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.biopha.2025.118532_bib10","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.annonc.2023.07.011","article-title":"Newly diagnosed and relapsed epithelial ovarian cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up\u2606","volume":"34","author":"Gonz\u00e1lez-Mart\u00edn","year":"2023","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.biopha.2025.118532_bib11","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.annonc.2023.11.015","article-title":"ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease","volume":"35","author":"Ledermann","year":"2024","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.biopha.2025.118532_bib12","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/annonc\/mdz062","article-title":"ESMO\u2013ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease","volume":"30","author":"Colombo","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.biopha.2025.118532_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00280-017-3501-8","article-title":"Advances in ovarian cancer therapy","volume":"81","author":"Cortez","year":"2018","journal-title":"Cancer Chemother. Pharm."},{"key":"10.1016\/j.biopha.2025.118532_bib14","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/PPO.0000000000000558","article-title":"Poly(ADP-Ribose) polymerase inhibitor inhibition in ovarian cancer: a comprehensive review","volume":"27","author":"Moore","year":"2021","journal-title":"Cancer J."},{"key":"10.1016\/j.biopha.2025.118532_bib15","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.annonc.2023.05.005","article-title":"Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1\/ENGOT-Ov25 trial","volume":"34","author":"Ray-Coquard","year":"2023","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.biopha.2025.118532_bib16","article-title":"Therapeutic chemoresistance in ovarian cancer: emerging hallmarks, signaling mechanisms and alternative pathways","author":"Zaib","year":"2024","journal-title":"Curr. Med Chem."},{"key":"10.1016\/j.biopha.2025.118532_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2024.117894","article-title":"Advancements in platinum-based anticancer drug development: a comprehensive review of strategies, discoveries, and future perspectives","volume":"112","author":"Sahoo","year":"2024","journal-title":"Bioorg. Med Chem."},{"key":"10.1016\/j.biopha.2025.118532_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.971905","article-title":"Anticancer regimens containing third generation taxanes SB-T-121605 and SB-T-121606 are highly effective in resistant ovarian carcinoma model","volume":"13","author":"Seborova","year":"2022","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2025.118532_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.109044","article-title":"Third-Generation taxanes SB-T-121605 and SB-T-121606 are effective in pancreatic ductal adenocarcinoma","volume":"27","author":"Sychra","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.biopha.2025.118532_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-022-00934-y","article-title":"Notch signaling pathway: architecture, disease, and therapeutics","volume":"7","author":"Zhou","year":"2022","journal-title":"Sig Transduct. Target Ther."},{"key":"10.1016\/j.biopha.2025.118532_bib21","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1146\/annurev-pathol-052016-100127","article-title":"The varied roles of notch in cancer","volume":"12","author":"Aster","year":"2017","journal-title":"Annu Rev. Pathol."},{"key":"10.1016\/j.biopha.2025.118532_bib22","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1182\/blood-2013-08-355818","article-title":"Notch signaling: switching an oncogene to a tumor suppressor","volume":"123","author":"Lobry","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2025.118532_bib23","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1002\/ijc.32293","article-title":"Nuclear orphan receptor NR2F6 confers cisplatin resistance in epithelial ovarian cancer cells by activating the Notch3 signaling pathway","volume":"145","author":"Li","year":"2019","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.biopha.2025.118532_bib24","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3892\/mmr.2021.12274","article-title":"Chemokine CCL20 promotes the paclitaxel resistance of CD44+CD117+ cells via the Notch1 signaling pathway in ovarian cancer","volume":"24","author":"Chen","year":"2021","journal-title":"Mol. Med Rep."},{"key":"10.1016\/j.biopha.2025.118532_bib25","doi-asserted-by":"crossref","first-page":"12369","DOI":"10.1007\/s13277-014-2551-3","article-title":"MicroRNA-449a reduces cell survival and enhances Cisplatin-Induced cytotoxicity via downregulation of NOTCH1 in ovarian cancer cells","volume":"35","author":"Zhou","year":"2014","journal-title":"Tumour Biol."},{"key":"10.1016\/j.biopha.2025.118532_bib26","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1309\/AJCPKDLRQ8F3EWNS","article-title":"Notch3 overexpression as potential therapeutic target in advanced stage chemoresistant ovarian cancer","volume":"138","author":"Rahman","year":"2012","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.biopha.2025.118532_bib27","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.ygyno.2011.12.013","article-title":"Integrated analysis of notch pathway in high grade serous ovarian cancer","volume":"125","author":"Hu","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.biopha.2025.118532_bib28","doi-asserted-by":"crossref","first-page":"6312","DOI":"10.1158\/0008-5472.CAN-05-3610","article-title":"Notch3 gene amplification in ovarian cancer","volume":"66","author":"Park","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2025.118532_bib29","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ygyno.2009.12.003","article-title":"Notch 1 signaling is active in ovarian cancer","volume":"117","author":"Rose","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.biopha.2025.118532_bib30","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","author":"Bell","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.118532_bib31","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.yexcr.2018.03.014","article-title":"Knockdown of MALAT1 enhances chemosensitivity of ovarian cancer cells to cisplatin through inhibiting the Notch1 signaling pathway","volume":"366","author":"Bai","year":"2018","journal-title":"Exp. Cell Res"},{"key":"10.1016\/j.biopha.2025.118532_bib32","doi-asserted-by":"crossref","first-page":"E2939","DOI":"10.1073\/pnas.1206400109","article-title":"Targeting notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy","volume":"109","author":"McAuliffe","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2025.118532_bib33","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejcsup.2007.12.003","article-title":"Management of partially platinum-sensitive relapsed ovarian cancer","volume":"6","author":"Kaye","year":"2008","journal-title":"Eur. J. Cancer Suppl."},{"key":"10.1016\/j.biopha.2025.118532_bib34","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1517\/14656566.3.6.755","article-title":"Paclitaxel in cancer therapy","volume":"3","author":"Markman","year":"2002","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.biopha.2025.118532_bib35","doi-asserted-by":"crossref","first-page":"451","DOI":"10.20517\/cdr.2021.138","article-title":"Ovarian cancer recurrence: \u201cIs the definition of platinum resistance modified by PARP inhibitors and other intervening treatments?","volume":"5","author":"Pejovic","year":"2022","journal-title":"Cancer Drug Resist"},{"key":"10.1016\/j.biopha.2025.118532_bib36","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1021\/np8006556","article-title":"Recent advances in the chemistry and biology of new generation taxoids","volume":"72","author":"Ojima","year":"2009","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.biopha.2025.118532_bib37","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1016\/j.bmc.2015.02.057","article-title":"Design, synthesis and biological evaluation of a Highly-Potent and cancer cell selective Folate-Taxoid conjugate","volume":"23","author":"Seitz","year":"2015","journal-title":"Bioorg. Med Chem."},{"key":"10.1016\/j.biopha.2025.118532_bib38","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1021\/acs.joc.7b03284","article-title":"Synthesis of a next-generation taxoid by rapid methylation amenable for 11C-labeling","volume":"83","author":"Seitz","year":"2018","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.biopha.2025.118532_bib39","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1021\/jm800086e","article-title":"Design, synthesis, and biological evaluation of new-generation taxoids","volume":"51","author":"Ojima","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2025.118532_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103523","article-title":"Design, synthesis and Sar study of 3rd-generation taxoids bearing 3-CH3, 3-CF3O and 3-CHF2O groups at the C2-Benzoate position","volume":"95","author":"Wang","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.biopha.2025.118532_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2024.116993","article-title":"Effect of substituents at the C3\u00b4, C3\u00b4N, C10 and C2-Meta-Benzoate positions of taxane derivatives on their activity against resistant cancer cells","volume":"489","author":"Daniel","year":"2024","journal-title":"Toxicol. Appl. Pharm."},{"key":"10.1016\/j.biopha.2025.118532_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/cyto.a.24840","article-title":"Simple, fast, cost-efficient, reliable, and highly automated DNA content analysis of cells in adherent cultures","author":"\u010c\u00ed\u017ekov\u00e1","year":"2024","journal-title":"Cytom. A"},{"key":"10.1016\/j.biopha.2025.118532_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232565","article-title":"An image j plugin for the high throughput image analysis of in vitro scratch wound healing assays","volume":"15","author":"Suarez-Arnedo","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.118532_bib44","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1634\/stemcells.2005-0066","article-title":"Expression of cytochrome P450 genes in CD34+ hematopoietic stem and progenitor cells","volume":"23","author":"Soucek","year":"2005","journal-title":"Stem Cells"},{"key":"10.1016\/j.biopha.2025.118532_bib45","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","article-title":"The MIQE guidelines: minimum information for publication of quantitative Real-Time PCR experiments","volume":"55","author":"Bustin","year":"2009","journal-title":"Clin. Chem."},{"key":"10.1016\/j.biopha.2025.118532_bib46","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using Real-Time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.biopha.2025.118532_bib47","doi-asserted-by":"crossref","first-page":"326","DOI":"10.5152\/tjg.2019.18550","article-title":"Upregulation of SIRT1 gene in gastric adenocarcinoma","volume":"30","author":"\u00d6zcan","year":"2019","journal-title":"Turk. J. Gastroenterol."},{"key":"10.1016\/j.biopha.2025.118532_bib48","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Stat. Soc. Ser. B Methodol."},{"key":"10.1016\/j.biopha.2025.118532_bib49","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1152\/physrev.00005.2017","article-title":"Notch signaling in development, tissue homeostasis, and disease","volume":"97","author":"Siebel","year":"2017","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.biopha.2025.118532_bib50","doi-asserted-by":"crossref","first-page":"6030","DOI":"10.1158\/0008-5472.CAN-10-2719","article-title":"Biological roles of the delta family notch ligand Dll4 in tumor and endothelial cells in ovarian cancer","volume":"71","author":"Hu","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2025.118532_bib51","first-page":"4914","article-title":"NOTCH2\/NOTCH3\/DLL3\/MAML1\/ADAM17 signaling network is associated with ovarian cancer","volume":"17","author":"Jia","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.biopha.2025.118532_bib52","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature10113","article-title":"Whole-Genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia","volume":"475","author":"Puente","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.118532_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-024-01828-x","article-title":"Notch signaling pathway in cancer: from mechanistic insights to targeted therapies","volume":"9","author":"Shi","year":"2024","journal-title":"Sig Transduct. Target Ther."},{"key":"10.1016\/j.biopha.2025.118532_bib54","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/medicines5010016","article-title":"Ovarian cancers: genetic abnormalities, tumor heterogeneity and progression, clonal evolution and cancer stem cells","volume":"5","author":"Testa","year":"2018","journal-title":"Medicines"},{"key":"10.1016\/j.biopha.2025.118532_bib55","doi-asserted-by":"crossref","first-page":"952","DOI":"10.3390\/ijms20040952","article-title":"High-Grade serous ovarian cancer: basic sciences, clinical and therapeutic standpoints","volume":"20","author":"Lisio","year":"2019","journal-title":"IJMS"},{"key":"10.1016\/j.biopha.2025.118532_bib56","doi-asserted-by":"crossref","first-page":"220","DOI":"10.31083\/j.fbl2809220","article-title":"NOTCH pathway genes in ovarian cancer: clinical significance and associations with immune cell infiltration","volume":"28","author":"Chen","year":"2023","journal-title":"Front Biosci. Landmark Ed."},{"key":"10.1016\/j.biopha.2025.118532_bib57","doi-asserted-by":"crossref","first-page":"32731","DOI":"10.18632\/oncotarget.16387","article-title":"Prognostic roles of notch receptor mRNA expression in human ovarian cancer","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2025.118532_bib58","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/IGC.0000000000000359","article-title":"Increased Notch1 expression is associated with poor overall survival in patients with ovarian cancer","volume":"25","author":"Alniaimi","year":"2015","journal-title":"Int J. Gynecol. Cancer"},{"key":"10.1016\/j.biopha.2025.118532_bib59","article-title":"Identification and validation of a novel Anoikis-Related signature for predicting prognosis and immune landscape in ovarian serous cystadenocarcinoma","volume":"9","author":"Zhu","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.biopha.2025.118532_bib60","doi-asserted-by":"crossref","first-page":"6975","DOI":"10.1002\/jcp.26619","article-title":"NOTCH4 regulates colorectal cancer proliferation, invasiveness, and determines clinical outcome of patients","volume":"233","author":"Zhang","year":"2018","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.biopha.2025.118532_bib61","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3892\/etm.2022.11400","article-title":"GRWD1 affects the proliferation, apoptosis, invasion and migration of triple negative breast cancer through the notch signaling pathway","volume":"24","author":"Yao","year":"2022","journal-title":"Exp. Ther. Med"},{"key":"10.1016\/j.biopha.2025.118532_bib62","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2353\/ajpath.2010.100316","article-title":"Notch3 overexpression is related to the recurrence of ovarian cancer and confers resistance to carboplatin","volume":"177","author":"Park","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biopha.2025.118532_bib63","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.7150\/jca.18955","article-title":"Correlation of ALDH1 and Notch3 expression: clinical implication in ovarian carcinomas","volume":"8","author":"Kim","year":"2017","journal-title":"J. Cancer"},{"key":"10.1016\/j.biopha.2025.118532_bib64","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/cam4.1812","article-title":"CCNG1 (Cyclin G1) regulation by Mutant-P53 via induction of Notch3 expression promotes High-Grade serous ovarian cancer (HGSOC) tumorigenesis and progression","volume":"8","author":"Xu","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.biopha.2025.118532_bib65","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5953498","article-title":"Overexpression of Notch3 and pS6 is associated with poor prognosis in human ovarian epithelial cancer","volume":"2016","author":"Liu","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.biopha.2025.118532_bib66","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.3892\/or.2017.5814","article-title":"Mangiferin induces apoptosis in human ovarian adenocarcinoma OVCAR3 cells via the regulation of Notch3","volume":"38","author":"Zou","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biopha.2025.118532_bib67","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ygyno.2013.03.019","article-title":"Notch3 induces Epithelial-Mesenchymal transition and attenuates Carboplatin-Induced apoptosis in ovarian cancer cells","volume":"130","author":"Gupta","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.biopha.2025.118532_bib68","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/mc.22363","article-title":"Notch3-Specific inhibition using siRNA knockdown or GSI sensitizes Paclitaxel-Resistant ovarian cancer cells","volume":"55","author":"Kang","year":"2016","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.biopha.2025.118532_bib69","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1158\/1535-7163.MCT-23-0314","article-title":"Targeting ovarian cancer stem cells by dual inhibition of the long noncoding RNA HOTAIR and lysine methyltransferase EZH2","volume":"23","author":"Wang","year":"2024","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.biopha.2025.118532_bib70","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ygyno.2015.03.005","article-title":"A phase II study of Single-Agent RO4929097, a Gamma-Secretase inhibitor of notch signaling, in patients with recurrent Platinum-Resistant epithelial ovarian cancer: a study of the princess margaret, Chicago and california phase II consortia","volume":"137","author":"Diaz-Padilla","year":"2015","journal-title":"Gynecol. Oncol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225007267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225007267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T23:22:30Z","timestamp":1778541750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225007267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":70,"alternative-id":["S0753332225007267"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118532","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular impact of NOTCH signaling dysregulation on ovarian cancer progression, chemoresistance, and taxane response","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118532","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118532"}}